Fig. 2

Complement C9 deposition in index newborn and mother. Complement C9 deposition after activation of the classic pathway in umbilical cord blood from preterm new born controls (box and whiskers plot), umbilical cord blood from the index newborn, in blood from the mother treated with eculizumab, and in blood from the index newborn at 3 weeks. Results are given for the deposition of complement C9 using the Palarasah-Nielsen-ELISA [9]